Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.
about
Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin DZinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transferComprehensive comparative analysis of strand-specific RNA sequencing methods.Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus.Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription.Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression.Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid proteinEffects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.Structural Insights into the HIV-1 Minus-strand Strong-stop DNA.The nature of actinomycin D binding to d(AACCAXYG) sequence motifs
P2860
Q28565709-A3F0272D-0608-49F3-A295-997591DB58F3Q33604321-878D84FC-52B9-4D60-BA35-7AC3CF193D83Q33658471-CFF0A483-9227-4AC9-87BE-ECA43D7087BFQ33813827-76B78F7F-5D1C-400E-99C8-7F8D85DF1305Q33827534-B65ED900-988F-4631-A714-24585BE221A1Q34351841-59785D0B-9CC8-4C73-BC6C-E857B70EA2B6Q34363753-3E43A400-FAC3-4E82-B4E2-3E13DBE68F8AQ34464355-1FF98AAA-A9D5-4AB8-8C35-D09C37EDB6C0Q34775658-61DDFA40-044D-4546-A832-1CF0796B943CQ34999333-4168607E-DBEA-4BAD-B161-2592B72B80CCQ35891627-95008202-D41D-48BC-922F-EB54514E96FEQ36328929-8503DBF7-B4DC-432B-BC8A-E17058EE1414Q36573996-6D397D7D-1956-4EB2-8870-5849CBBFFEAAQ37068344-27C801A1-F303-4E70-A884-C29EA5517ADA
P2860
Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@ast
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@en
type
label
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@ast
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@en
prefLabel
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@ast
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@en
P2093
P2860
P1433
P1476
Actinomycin D inhibits human i ...... reverse transcriptase assays.
@en
P2093
P2860
P304
P577
1998-08-01T00:00:00Z